Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1976 2
1977 1
1978 1
1979 2
1980 2
1981 2
1982 2
1983 5
1984 2
1985 3
1986 5
1987 4
1988 5
1989 2
1990 6
1991 4
1992 5
1993 5
1994 9
1995 10
1996 10
1997 11
1998 13
1999 10
2000 21
2001 15
2002 21
2003 18
2004 13
2005 28
2006 30
2007 36
2008 34
2009 26
2010 37
2011 33
2012 49
2013 39
2014 44
2015 45
2016 38
2017 45
2018 56
2019 56
2020 49
2021 57
2022 56
2023 50
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

915 results

Results by year

Filters applied: . Clear all
Page 1
An Updated Review of Pemphigus Diseases.
Malik AM, Tupchong S, Huang S, Are A, Hsu S, Motaparthi K. Malik AM, et al. Medicina (Kaunas). 2021 Oct 9;57(10):1080. doi: 10.3390/medicina57101080. Medicina (Kaunas). 2021. PMID: 34684117 Free PMC article. Review.
Clinicians may encounter a variety of skin conditions that present with vesiculobullous lesions in their everyday practice. Pemphigus vulgaris, pemphigus foliaceus, IgA pemphigus, and paraneoplastic pemphigus represent the spectrum of autoimmune bullous dermatoses o …
Clinicians may encounter a variety of skin conditions that present with vesiculobullous lesions in their everyday practice. Pemphigus …
Pemphigus group: overview, epidemiology, mortality, and comorbidities.
Kridin K. Kridin K. Immunol Res. 2018 Apr;66(2):255-270. doi: 10.1007/s12026-018-8986-7. Immunol Res. 2018. PMID: 29479654 Review.
This review provides a brief overview about the different subtypes of pemphigus: pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus, pemphigus herpetiformis, and IgA pemphigus. ...
This review provides a brief overview about the different subtypes of pemphigus: pemphigus vulgaris, pemphigus foliaceus, para …
Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes.
Cura MJ, Torre AC, Cueto Sarmiento KY, Bollea Garlatti ML, Riganti J, Puga MC, Mazzuoccolo LD. Cura MJ, et al. Actas Dermosifiliogr (Engl Ed). 2020 Jun;111(5):398-407. doi: 10.1016/j.ad.2019.10.004. Epub 2020 May 25. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 32466985 Free article. English, Spanish.
BACKGROUND: Pemphigus vulgaris (PV) is an uncommon, serious disease that is treated with systemic corticosteroids and corticosteroid-sparing agents. ...
BACKGROUND: Pemphigus vulgaris (PV) is an uncommon, serious disease that is treated with systemic corticosteroids and corticos …
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
Goebeler M, Bata-Csörgő Z, De Simone C, Didona B, Remenyik E, Reznichenko N, Stoevesandt J, Ward ES, Parys W, de Haard H, Dupuy P, Verheesen P, Schmidt E, Joly P; ARGX-113-1701 Investigator Study Group. Goebeler M, et al. Br J Dermatol. 2022 Mar;186(3):429-439. doi: 10.1111/bjd.20782. Epub 2021 Nov 28. Br J Dermatol. 2022. PMID: 34608631 Clinical Trial.
BACKGROUND: Pemphigus vulgaris and pemphigus foliaceus are potentially life-threatening autoimmune disorders triggered by IgG autoantibodies against mucosal and epidermal desmogleins. ...OBJECTIVES: To investigate efgartigimod, an engineered Fc fragment that inhibit …
BACKGROUND: Pemphigus vulgaris and pemphigus foliaceus are potentially life-threatening autoimmune disorders triggered by IgG …
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM; PEMPHIX Study Group. Werth VP, et al. N Engl J Med. 2021 Jun 17;384(24):2295-2305. doi: 10.1056/NEJMoa2028564. Epub 2021 May 19. N Engl J Med. 2021. PMID: 34097368 Clinical Trial.
BACKGROUND: Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials. ...CONCLUSIONS: Rituximab was superior to mycophenolate mofetil in producing sustained complete remission at 52 weeks …
BACKGROUND: Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compar …
Autoimmune bullous dermatoses.
Holtsche MM, Boch K, Schmidt E. Holtsche MM, et al. J Dtsch Dermatol Ges. 2023 Apr;21(4):405-412. doi: 10.1111/ddg.15046. J Dtsch Dermatol Ges. 2023. PMID: 37070500 Review.
The development of various in vitro and in vivo models of the most common AIBD, namely, bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, and the rare epidermolysis bullosa acquisita, allows identification of key molecules and inflammatory pathways …
The development of various in vitro and in vivo models of the most common AIBD, namely, bullous pemphigoid, pemphigus vulgaris …
Pemphigus.
Korman N. Korman N. J Am Acad Dermatol. 1988 Jun;18(6):1219-38. doi: 10.1016/s0190-9622(88)70128-0. J Am Acad Dermatol. 1988. PMID: 3290286 Review.
Another model proposes that pemphigus antibodies fix complement and thereby alter cell membrane integrity to produce acantholysis. Prior to the availability of corticosteroids, pemphigus vulgaris was commonly fatal. Treatment with glucocorticosteroids has drasticall …
Another model proposes that pemphigus antibodies fix complement and thereby alter cell membrane integrity to produce acantholysis. Prior to …
Pemphigus: Pathogenesis to Treatment.
DiMarco C. DiMarco C. R I Med J (2013). 2016 Dec 1;99(12):28-31. R I Med J (2013). 2016. PMID: 27902996 Review.
Pemphigus vulgaris (PV), pemphigus foliaceus (PF), and paraneoplastic pemphigus (PNP) are a group of rare and fatal blistering diseases involving autoantibodies that target desmosomal proteins. ...
Pemphigus vulgaris (PV), pemphigus foliaceus (PF), and paraneoplastic pemphigus (PNP) are a group of rare and fatal blistering …
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
Rosi-Schumacher M, Baker J, Waris J, Seiffert-Sinha K, Sinha AA. Rosi-Schumacher M, et al. Front Immunol. 2023 Apr 25;14:1159351. doi: 10.3389/fimmu.2023.1159351. eCollection 2023. Front Immunol. 2023. PMID: 37180132 Free PMC article. Review.
Autoimmune blistering diseases such as bullous pemphigoid (BP) and pemphigus vulgaris (PV) are complex, multifactorial, and polygenic diseases, whose exact pathogenesis is difficult to pinpoint. ...
Autoimmune blistering diseases such as bullous pemphigoid (BP) and pemphigus vulgaris (PV) are complex, multifactorial, and po …
915 results